Group | Number of cases | WBC (×109/L) | CRP(mg/L) | IL-6 (pg/mL) | TNF-α (pg/mL) | ||||
Before treatment | After treatment | Before treatment | After treatment | Before treatment | After treatment | Before treatment | After treatment | ||
control group | 60 | 27.45 ± 5.16 | 10.29 ± 0.57 | 8.62 ± 2.25 | 6.47 ± 1.38 | 44.13 ± 2.88 | 21.07 ± 1.98 | 25.25 ± 5.43 | 17.46 ± 3.19 |
experimental Group | 60 | 27.11 ± 6.27 | 8.93 ± 0.43 | 8.65 ± 2.24 | 5.01 ± 1.63 | 44.04 ± 2.65 | 12.43 ± 1.28 | 25.39 ± 4.85 | 14.88 ± 2.31 |
t | - | 0.324 | 3.054 | 0.073 | 3.195 | 0.178 | 3.886 | 0.149 | 3.374 |
P | - | 0.746 | 0.000 | 0.942 | 0.000 | 0.859 | 0.000 | 0.882 | 0.000 |